All Cleveland Clinic articles
-
NewsResearch links tumor bacteria to immunotherapy resistance in head and neck cancer
Two new studies reveal that elevated levels of bacteria in the tumor microenvironment suppress immune response, driving resistance to immunotherapy in patients with head and neck squamous cell carcinoma.
-
NewsEvolutionary model for antibiotic resistance reveals dose timing critical to care
The study that uses a “fitness seascape” to incorporate a patient’s dosage schedule into models that predict whether an infection will develop antibiotic resistance has found that inconsistent timing and missing early doses can lead to treatment failure.
-
NewsStudy finds immune protein modification blocks viral replication, heart inflammation
New research shows protein modifications to the immune sensor MDA5 reduce viral replication and may lead to broad-spectrum antiviral breakthroughs.
-
NewsStudy finds artificial intelligence can develop treatments to prevent superbugs
Researchers developed an AI model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on how quickly the bacteria grow given certain perturbations.
-
NewsResearchers uncover how virus causes cancer, point to potential treatment
Kaposi sarcoma-associated herpesvirus activates a specific pathway to drive viral persistent infection and cell growth, paving the way for tumors to form.